We are live on ! Find out more
ORC

O'Rourke & Company Portfolio holdings

AUM $253M
1-Year Est. Return 16.72%
This Fund
S&P 500
This Quarter Est. Return
+3.63%
1 Year Est. Return
+16.72%
3 Year Est. Return
+62.38%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$178M
AUM Growth
+$5.42M
Cap. Flow
+$136K
Cap. Flow %
0.08%
Top 10 Hldgs %
41.51%
Holding
146
New
4
Increased
87
Reduced
32
Closed
4

Top Buys

Rank Stock Value
1
NOBL icon
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
+$347K
2
VPU
Vanguard Utilities ETF
VPU
+$302K
3
BMY icon
Bristol-Myers Squibb
BMY
+$260K
4
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$255K
5
VBR icon
Vanguard Morningstar Small-Cap Value ETF
VBR
+$250K

Top Sells

Rank Stock Value
1
PGX icon
Invesco Preferred ETF
PGX
+$1.85M
2
GSK icon
GSK
GSK
+$864K
3
VCIT icon
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
+$325K
4
UPS icon
United Parcel Service
UPS
+$212K
5
DOW icon
Dow Inc
DOW
+$203K

Sector Composition

Rank Sector Weight
1 Financials 17.43%
2 Technology 17.31%
3 Communication Services 4.14%
4 Healthcare 3.22%
5 Consumer Discretionary 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CWB icon
26
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.72B
$1.69M 0.95%
23,422
-164
-0.7% -$11.7K
VDE icon
27
Vanguard Energy ETF
VDE
$9.81B
$1.59M 0.9%
12,479
+925
+8% +$120K
GS icon
28
Goldman Sachs
GS
$312B
$1.46M 0.82%
3,217
+4
+0.1% +$1.75K
SPY icon
29
State Street SPDR S&P 500 ETF Trust
SPY
$814B
$1.41M 0.8%
2,597
+183
+8% +$95.8K
JNJ icon
30
Johnson & Johnson
JNJ
$608B
$1.3M 0.73%
8,916
-342
-4% -$50.9K
VYM icon
31
Vanguard High Dividend Yield ETF
VYM
$81.8B
$1.28M 0.72%
10,799
+843
+8% +$100K
CIBR icon
32
First Trust NASDAQ Cybersecurity ETF
CIBR
$15.1B
$1.2M 0.67%
21,196
-363
-2% -$19.9K
KO icon
33
Coca-Cola
KO
$371B
$1.18M 0.66%
18,509
-34
-0.2% -$2.1K
PAVE icon
34
Global X US Infrastructure Development ETF
PAVE
$14.9B
$1.14M 0.64%
30,857
+7
+0% +$268
IGHG icon
35
ProShares Investment Grade-Interest Rate Hedged
IGHG
$329M
$1.13M 0.64%
14,806
-175
-1% -$13.4K
VB icon
36
Vanguard Morningstar Small-Cap ETF
VB
$81.3B
$1.1M 0.62%
5,068
– –
ADI icon
37
Analog Devices
ADI
$183B
$1.09M 0.61%
4,758
– –
DVY icon
38
iShares Select Dividend ETF
DVY
$23.5B
$1.02M 0.57%
8,438
+577
+7% +$70K
LLY icon
39
Eli Lilly
LLY
$1T
$1.01M 0.57%
1,112
+29
+3% +$23.2K
VIG icon
40
Vanguard Dividend Appreciation ETF
VIG
$113B
$988K 0.56%
5,413
-70
-1% -$12.6K
XLRE icon
41
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.54B
$951K 0.54%
24,750
+2,632
+12% +$99.1K
SCHW
42
Charles Schwab
SCHW
$184B
$947K 0.53%
12,857
-386
-3% -$28.5K
IBB icon
43
iShares Biotechnology ETF
IBB
$9.23B
$909K 0.51%
6,625
– –
PG icon
44
Procter & Gamble
PG
$340B
$898K 0.51%
5,446
+4
+0.1% +$654
XLV icon
45
State Street Health Care Select Sector SPDR ETF
XLV
$41.5B
$874K 0.49%
5,996
+282
+5% +$40.5K
WMT icon
46
Walmart Inc
WMT
$875B
$858K 0.48%
12,670
+5
+0% +$315
VOE icon
47
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.8B
$840K 0.47%
5,587
+343
+7% +$52K
KMI icon
48
Kinder Morgan
KMI
$68.9B
$839K 0.47%
42,226
+148
+0.4% +$2.82K
XLP icon
49
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.8B
$836K 0.47%
10,922
+151
+1% +$11.5K
MRK icon
50
Merck
MRK
$317B
$795K 0.45%
6,425
+6
+0.1% +$773
1
2
3 4 5

Similar funds

RA
Ruggaard & Associates Hudson, Ohio $252M AUM 14.53% 1-Year Est. Return
N
Naspers South Africa $253M AUM 25.32% 1-Year Est. Return
PI
PJT Investments Toronto $252M AUM 3.52% 1-Year Est. Return
JWM
Jupiter Wealth Management Glendale, Colorado $253M AUM 32.44% 1-Year Est. Return
ACM
Avos Capital Management Seattle, Washington $253M AUM 13.56% 1-Year Est. Return
MWM
MorganRosel Wealth Management Highlands Ranch, Colorado $254M AUM 18.87% 1-Year Est. Return
TODC
Trustees of Dartmouth College Hanover, New Hampshire $252M AUM 12.95% 1-Year Est. Return
LI
LHM Inc Sandy, Utah $254M AUM 13.16% 1-Year Est. Return

O'Rourke & Company's Q2 2024 Portfolio in Review

As of Q2 2024, O'Rourke & Company held 146 positions worth $178M, up 3.1% from $172M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

O'Rourke & Company's Q2 2024 filing shows 4 new, 87 increased, 32 reduced and 4 closed positions. Its largest new stake was Bristol-Myers Squibb: 5,801 shares worth $241K. The largest sale was Invesco Preferred ETF, an estimated $1.85M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Communication Services.

  • O'Rourke & Company's largest Q2 2024 buy was Bristol-Myers Squibb: 5,801 shares worth $241K.
  • O'Rourke & Company added most to ProShares S&P 500 Dividend Aristocrats ETF in Q2 2024, an estimated $347K increase.
  • O'Rourke & Company's biggest Q2 2024 reduction was Invesco Preferred ETF, cutting an estimated $1.85M.
  • O'Rourke & Company fully exited GSK in Q2 2024, selling an estimated $864K.
  • O'Rourke & Company's ten largest holdings make up 42% of its $178M portfolio in Q2 2024.
  • O'Rourke & Company opened 4 new positions and closed 4 in Q2 2024.
  • O'Rourke & Company's portfolio value rose 3.1% quarter-over-quarter to $178M.

Based on O'Rourke & Company's 13F filing for Q2 2024, filed 18 Jul 2024.